Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

A. S. Dincq; S. Lessire; G. Pirard; R. Siriez; M. Guldenpfennig; J. Baudar; J. Favresse; J. Douxfils; F. Mullier

doi:10.1111/ijlh.12870

Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

A. S. Dincq, S. Lessire, G. Pirard, R. Siriez, M. Guldenpfennig, J. Baudar, J. Favresse, J. Douxfils, F. Mullier

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e105-e108
Number of pages	4
Journal	International Journal of Laboratory Hematology
Volume	40
Issue number	6
Early online date	2018
DOIs	https://doi.org/10.1111/ijlh.12870
Publication status	Published - 1 Dec 2018

Access to Document

10.1111/ijlh.12870

Cite this

Dincq, A. S., Lessire, S., Pirard, G., Siriez, R., Guldenpfennig, M., Baudar, J., Favresse, J., Douxfils, J., & Mullier, F. (2018). Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method. International Journal of Laboratory Hematology, 40(6), e105-e108. https://doi.org/10.1111/ijlh.12870

@article{85283b5a82a1444b975115840e5d5b30,

title = "Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method",

author = "Dincq, {A. S.} and S. Lessire and G. Pirard and R. Siriez and M. Guldenpfennig and J. Baudar and J. Favresse and J. Douxfils and F. Mullier",

note = "Funding Information: F.Mullier: research support from Stago, Werfen, Nodia, Sysmex and Bayer (institutional fees), speaker fees from Boehringer Ingelheim, Bayer Healthcare and Bristol-Myers Squibb-Pfizer. J. Douxfils: CEO of QUALIblood sa, research support from Stago, speaker fees from Stago, Roche Diagnostics, Roche, Daiichi Sankyo. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2018",

month = dec,

day = "1",

doi = "10.1111/ijlh.12870",

language = "English",

volume = "40",

pages = "e105--e108",

journal = "International Journal of Laboratory Hematology",

issn = "1751-5521",

publisher = "Wiley-Blackwell Publishing",

number = "6",

}

Dincq, AS, Lessire, S, Pirard, G, Siriez, R, Guldenpfennig, M, Baudar, J, Favresse, J, Douxfils, J & Mullier, F 2018, 'Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method', International Journal of Laboratory Hematology, vol. 40, no. 6, pp. e105-e108. https://doi.org/10.1111/ijlh.12870

TY - JOUR

T1 - Reduction of the turn-around time for the measurement of rivaroxaban and apixaban

T2 - Assessment of the performance of a rapid centrifugation method

AU - Dincq, A. S.

AU - Lessire, S.

AU - Pirard, G.

AU - Siriez, R.

AU - Guldenpfennig, M.

AU - Baudar, J.

AU - Favresse, J.

AU - Douxfils, J.

AU - Mullier, F.

N1 - Funding Information: F.Mullier: research support from Stago, Werfen, Nodia, Sysmex and Bayer (institutional fees), speaker fees from Boehringer Ingelheim, Bayer Healthcare and Bristol-Myers Squibb-Pfizer. J. Douxfils: CEO of QUALIblood sa, research support from Stago, speaker fees from Stago, Roche Diagnostics, Roche, Daiichi Sankyo. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2018/12/1

Y1 - 2018/12/1

UR - http://www.scopus.com/inward/record.url?scp=85056197147&partnerID=8YFLogxK

U2 - 10.1111/ijlh.12870

DO - 10.1111/ijlh.12870

M3 - Article

C2 - 29920946

SN - 1751-5521

VL - 40

SP - e105-e108

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

IS - 6

ER -

Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

Access to Document

Other files and links

The BIOCOAG project : Biological assessment of the control of anticoagulation

Cite this

Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

Access to Document

Other files and links

Projects

The BIOCOAG project : Biological assessment of the control of anticoagulation

Cite this